» Articles » PMID: 32967778

The Effects of Mepolizumab on Peripheral Circulation and Neurological Symptoms in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Patients

Overview
Journal Allergol Int
Publisher Elsevier
Date 2020 Sep 24
PMID 32967778
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Unveiling the Uncommon: A Case of Eosinophilic Granulomatosis With Polyangiitis Featuring Atypical Presentation and Diagnostic Challenges.

Macedo D, Goncalves A, Pais A, Silva A, Clara Coelho A, Cacola R Cureus. 2024; 16(10):e72564.

PMID: 39606502 PMC: 11601993. DOI: 10.7759/cureus.72564.


Successful Treatment of Eosinophilic Granulomatosis With Polyangiitis: A Case of Refractory Peripheral Neuropathy and Comorbid Chronic Progressive Pulmonary Aspergillosis Treated With Mepolizumab.

Sekiya R, Soma T, Nakagome K, Nagata M Cureus. 2024; 16(1):e52192.

PMID: 38222984 PMC: 10787210. DOI: 10.7759/cureus.52192.


Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations.

Watanabe R, Hashimoto M J Clin Med. 2023; 12(18).

PMID: 37762936 PMC: 10532073. DOI: 10.3390/jcm12185996.


The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review.

Kouverianos I, Angelopoulos A, Daoussis D Rheumatol Int. 2023; 43(7):1245-1252.

PMID: 37085573 PMC: 10185576. DOI: 10.1007/s00296-023-05326-1.


Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation.

Sato M, Yatomi M, Wakamatsu I, Uno S, Hanazato C, Masuda T Respir Med Case Rep. 2023; 43:101818.

PMID: 36950026 PMC: 10025129. DOI: 10.1016/j.rmcr.2023.101818.